Filing Details
- Accession Number:
- 0001127602-23-029809
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-18 16:07:38
- Reporting Period:
- 2023-12-14
- Accepted Time:
- 2023-12-18 16:07:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1632780 | L Victoria Creamer | 251 Ballardvale Street Wilmington MA 01887 | Evp & Chief People Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-14 | 3,381 | $144.67 | 19,887 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-12-14 | 2,145 | $124.13 | 22,032 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-12-14 | 5,526 | $225.00 | 16,506 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2023-12-14 | 3,381 | $0.00 | 3,381 | $144.67 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2023-12-14 | 2,145 | $0.00 | 2,145 | $124.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-02-22 | 2024-02-22 | No | 4 | M | Direct |
| 0 | 2020-02-01 | 2024-02-01 | No | 4 | M | Direct |
Footnotes
- This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on August 16, 2023.
Billionaire Hedge Funds
